Are randomised controlled trials in the BMJ different?

BMJ

Volumn 323, Issue 7323, 2001, Pages 1253-

  Bartlett, Christopher ^a   Jüni, Peter ^b   Egger, Matthias ^b  

^a MRC Health Services Research Collaboration   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG SCREENING; HUMAN; LETTER; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE;

DRUG THERAPY; GREAT BRITAIN; HUMANS; PERIODICALS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 0035944756     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.323.7323.1253a     Document Type: Letter

References (4)

1. Egger M, Jüni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA 2001; 285: 1996–1999.
2. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663–694.
3. Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000; 355: 2037–2040.
4. Chalmers I. What do I want from health research and researchers when I am a patient? BMJ 1995; 310: 1315–1318.